Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
On Aug. 27, 2026, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has approved…
-
-
L’Oréal and Institut Pasteur announce historic partnership to advance skin health science
On Apr. 2, 2026, L’Oréal and the Institut Pasteur announced a landmark research partnership, marking a historic first…
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 23, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
Artificial Intelligence | Biotechnology | Genomics | Infectious Disease | Nanotechnology | Neurology | NIH | Non-Profit Research | Quantum | Stem Cell | Therapeutics | U.S. Congress
Dozens of researchers will move to France from US following high-profile bid to lure talent
On Feb. 10, 2026, France announced late last week that it would be awarding funds to 46 scientists…
-
WHO reported Middle East respiratory syndrome coronavirus outbreak continues
On Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as…
-
Biotechnology | Diagnostics | Environmental | Forestry | Genomics | Marine Science | Non-Profit Research
Once thought a fantasy, effort to sequence DNA of millions of species gains momentum
On Nov. 4, 2025, six years ago this month, scientists launched a massively ambitious effort to sequence the…
-
Study suggests two unsuspected pathogens struck Napoleon’s army during the retreat from Russia in 1812
On Oct. 24, 2025, scientists from the Institut Pasteur announced they have genetically analyzed the remains of former…
-
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
On Aug. 26, 2025, Osivax announced it has secured $19.5 million in funding from the Biomedical Advanced Research…
-
Sanofi to acquire Vicebio for $1.15 Billion, expanding respiratory vaccines pipeline
On Jul. 22, 2025, Sanofi announces it has entered into an agreement to acquire Vicebio, a privately held…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
-
Sanofi to acquire Blueprint Medicines for $9.1 Billion
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
-
Sanofi to invest $20 billion in U.S. through 2030
On Mar. 14, 2025, Sanofi announced that it plans to invest at least $20 billion in the United…
-
Genome study shows how horses galloped into human history
On Jun. 7, 2024, the Institute of Evolutionary Biology in Barcelona announced an analysis of genome data from…
-
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported nine cases of severe neonatal sepsis associated with hepatic impairment and multi-organ failure…
-
France reported bird flu in foxes near Paris
On Mar. 7, 2023, the the World Organisation for Animal Health (WOAH) announced that France had reported an…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 heroes & Remembrance
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
-
Moderna announced Recipharm site in France manufacturing COVID-19 Vaccine following approval by EMA
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…
-
Newly licensed U.S. manufacturing facility increased availability of Fluzone high-dose quadrivalent (influenza vaccine)
On Jun. 17, 2021, the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research granted…
-
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
-
Sanofi and GSK COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in Phase 2 trial
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
-
Oxford University researchers released cheap, quick COVID-19 antibody test
On Mar. 29, 2021, an international research team led by Oxford University scientists announced they had developed a…
-
Valneva announced IXIARO supply contract with the U.S. Government worth up to $166 million
On Sept. 9, 2020, Valneva announced the signing of a new contract, lasting up to three years, with…
-
Sanofi acquired Principia Biopharma for $3.68 billion
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
-
Sanofi and GSK announced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
-
Sanofi and GSK agreed with the UK government to supply up to 60 million doses of COVID-19 vaccine
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
-
BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
-
Abivax treated first patient in phase 2b/3 ABX464 Covid-19 clinical trial
On Jul. 2, 2020, French biotech company Abivax announced it had has treated the first patient in a…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
AgReliant Genetics was founded
Jul. 1, 2020, was the twentieth anniversary of AgReliant Genetics’ founding by global seed companies KWS of Einbeck,…
-
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage…
